A citation-based method for searching scientific literature

Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren, Vincent Woo, Oluf Hansen, Anders G Holst, Jonas Pettersson, Tina Vilsbøll. N Engl J Med 2016
Times Cited: 2052

List of shared articles

Times cited

Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.
Christie A Schumacher, Elizabeth K Van Dril, Kayce M Shealy, Jennifer D Goldman. Clin Diabetes 2021

Using adjuvant pharmacotherapy in the treatment of type 1 diabetes.
Åke Sjöholm. Expert Opin Pharmacother 2021

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
Abhinav Sharma, Haya Aziz, Subodh Verma, Beth L Abramson, Richard Choi, Grace L Chua, Kim A Connelly, George Honos, G B John Mancini, Sarah A Ramer,[...]. Curr Opin Cardiol 2021

Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes.
Renata Libianto, Timothy Me Davis, Elif I Ekinci. Med J Aust 2020

Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
Tanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, Jonathan D Newman. J Am Coll Cardiol 2020

2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
Chern-En Chiang, Kwo-Chang Ueng, Ting-Hsing Chao, Tsung-Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih-Hsien Sung, Hung-I Yeh, Yi-Heng Li, Ping-Yen Liu,[...]. J Chin Med Assoc 2020

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.
Sandeep R Das, Brendan M Everett, Kim K Birtcher, Jenifer M Brown, James L Januzzi, Rita R Kalyani, Mikhail Kosiborod, Melissa Magwire, Pamela B Morris, Joshua J Neumiller,[...]. J Am Coll Cardiol 2020

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Guntram Schernthaner, Naim Shehadeh, Alexander S Ametov, Anna V Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M Lalić,[...]. Cardiovasc Diabetol 2020